Login / Signup

Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation.

Marlou T H F JanssenJosef S SmolenRobert B M LandeweCésar Magro-ChecaRémy L M Mostard
Published in: Annals of the rheumatic diseases (2021)
Keyphrases
  • sars cov
  • rheumatoid arthritis
  • respiratory syndrome coronavirus
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • coronavirus disease